Daclizumab Subcutaneous and Fiasp Injection
Determining the interaction of Daclizumab Subcutaneous and Fiasp Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Fiasp
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Fiber Lax
- Daclizumab Subcutaneous-Fiber Laxative
- Daclizumab Subcutaneous-FiberCon
- Daclizumab Subcutaneous-FiberGen
- Daclizumab Subcutaneous-Fibertab
- Daclizumab Subcutaneous-Fibricor
- Fiasp Injection-Dacogen
- Fiasp Injection-Dacomitinib
- Fiasp Injection-Dactinomycin
- Fiasp Injection-Dactinomycin Injection
- Fiasp Injection-Dactinomycin Intravenous
- Fiasp Injection-Daklinza